Clinically, GFR is used to stage kidney disease, guide treatment decisions, and monitor the progression of renal conditions. For instance, a GFR below 60 mL/min/1.73 m² for three months or more is indicative of CKD. Understanding the relationship between histological findings and GFR can help healthcare providers develop targeted treatment plans to preserve kidney function.